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Summary Gene amplification is a mechanism whereby cultured animal cells and human tumours become
resistant to cancer chemotherapeutic agents. This review of studies from the authors' laboratory describes
properties of the acquisition of resistance to methotrexate in cultured mammalian cells by virtue of
amplification of the dihydrofolate reductase gene. These properties result in a heterogeneous cell population
with respect to many cell properties, including the number and stability of the amplified genes. Gene
amplification results from overreplication of DNA in a single cell cycle as a result of inhibition of DNA
synthesis. The cells surviving such overreplication constitute a heterogeneous population with multiple
chromosomal changes, including partial or complete endoreduplication of chromosomes, as well as a variety
of chromosomal rearrangements. A similar phenomenon may underlie the generation of aneuploidy in
tumours, their malignant progression, and the generation of heterogeneity in the tumour cell population.
The heterogeneity in properties of cells in many
tumours, in particular solid tumours, is a well
documented phenomenon. One such phenomenon is
resistance to chemotherapeutic agents. This paper
will review studies from the authors' laboratory
concerning the acquisition of resistance to
methotrexate (MTX) as a consequence of
amplification of the dihydrofolate reductase
(DHFR) gene, and will emphasize those aspects of
amplification events that result in marked
heterogeneity in cell populations. Gene amplifi-
cation, which involves overreplication of DNA in a
single cell cycle, results in a wide variety of
chromosomal rearrangements, and may be a
mechanism that produces heterogeneity in cell
properties in a variety of solid tumour cell
populations. The interested reader is referred to
Schimke (1984a) for a review of the subject of gene
amplification in somatic cells. For the more
clinically inclined, the problem of clinical emergence
of resistance is discussed by Schimke (1984b).
Properties ofdihydrofolate reductase gene
amplification
Three mechanisms have been described for
acquisition of resistance in cells grown continuously
*Delivered at the Joint Meeting of the British Association
for Cancer Research at the Royal Society of Medicine
(Section of Oncology), Nov. 22-23, 1984.
Correspondence: R.T. Schimke.
Received 18 December 1984.
in MTX: (1) alteration in affinity of MTX for
DHFR (Haber et al., 1981); (2) altered transport of
MTX (Sirotnak et al., 1981); (3) overproduction of
DHFR as a result of gene amplification. These
mechanisms are not mutually exclusive and multiple
modes of resistance can occur in the same cells.
Resistance resulting from gene amplification has the
following properties:
1. Resistance is a result of step-wise selection,
resulting ultimately in cells with high resistance and
gene copy number. We interpret this finding to
indicate that gene amplifications occur in small
increments, thus requiring multiple step selections
to obtain highly resistant cells by an amplification
mechanism.
2. Resistance results from overproduction of a
normal protein. In the case of MTX, resistance
results from the fact that there is sufficient
overproduction of DHFR to overcome enzyme
inhibition, i.e. a titration of MTX by enzyme.
3. The resistance phenotype and amplified genes
can be either stable or unstable. When the genes
are stable, they reside on one or more
chromosomes, often constituting expanded regions
of chromosomes, so-called homogeneous staining
regions (HSRs) (Beidler & Spengler, 1976; Nunberg
et al., 1978). When the genes are unstable, they
reside on extrachromosomal elements called minute
chromosomes. Such elements replicate in the cell
cycle, but do not contain centromeric regions;
hence they can undergo micronucleation and
unequal distribution into daughter cells at mitosis,
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resulting in their instability (Schimke et al., 1981).
When cells are first selected for resistance and gene
amplification, the population is comprised
predominantly of cells with unstably amplified
genes. Thus a "hallmark" of gene amplification is
instability of the phenotype. However, when cells
are maintained under selection conditions for long
time periods, the cells that emerge often have stably
amplified genes (Kaufman & Schimke, 1981). The
tendency toward stable vs. unstable modes of gene
amplification varies among different cell types.
Empirically, cell lines that are highly aneuploid are
more likely to have extrachromosomally amplified
genes. We propose that the two modes of gene
amplification arise from the same initial event, i.e.
overreplication of DNA (Mariani & Schimke, 1984)
and the chromosomal localization of rereplicated
genes is the consequence of secondary recom-
bination events. If the overreplicated DNA
recombines to form a circular structure (Hamkalo
et al., 1985) it will constitute an extrachromosomal
minute chromosome. If, as a postulated rarer event,
the overreplicated DNA recombines into the
chromosome, this would result in amplification at
the site of the resident (non-amplified) gene (see
Schimke et al., 1981, Schimke, 1984a for detailed
discussions). Cell populations, therefore, will be
vastly heterogeneous with respect to both the
number and localization of amplified genes (see
Kaufman & Schimke, 1981; Kaufman et al., 1981
for examples of such heterogeneity).
4. The same MTX resistance phenotype can
result from amplification of two different DNA
sequences. In Leishmania tropica we have found
that resistance can occur by virtue of amplification
of two completely different DNA sequences
(Beverley et al., 1984). Such variability in the
molecular events resulting in the same phenotype
constitutes an additional form of heterogeneity in
cells.
5. MTX resistance resulting from DHFR gene
amplification occurs in instances of clinical
importance, i.e. cells obtained from patients treated
with MTX (Curd et al., 1983; Horns et al., 1984;
Trent et al., 1984; Carman et al., 1984).
6. The spontaneous frequency of gene amplifi-
cation in cultured animal cells is extremely high. As
studied under non-selective conditions, and
employing the fluorescence activated cell sorter, the
frequency of amplification of the DHFR gene is
10-3 events per cell generation (Johnson et al.,
1983). This frequency is 102 higher than frequencies
estimated by clonal methods employing MTX
selection conditions (Brown et al., 1983; Tlsty et al.,
1984) because the fluorescence cell sorter is a much
more sensitive means of detecting small changes in
DHFR gene copy number than are the clonal
selection methods.
7. The frequency of DHFR gene amplification
can be increased dramatically by a variety of agents
that inhibit reversibly DNA synthesis, including
MTX (Tlsty et al., 1982), hydroxyurea (Brown et
al., 1983), UV light and the carcinogen N-acetoxy
N-acetylaminofluorene (Tlsty et al., 1984).
Although many of these agents produce "damage"
in DNA, among their consequences is inhibition of
DNA synthesis current findings in the laboratory
suggest that it is the property of reversible
inhibition of DNA synthesis that is important in
the generation of gene amplification (see below).
8. Gene amplification is a common phenomenon
in biology and is being reported increasingly in
somatic cells. Amplification has been reported for a
number of specific genes, including CAD (Wahl et
al., 1979), metallothionine (Beach & Palmiter,
1981), Hydroxymethylglutaryl CoA reductase (Chin
et al., 1982), adenosine deaminase (Yeung et al.,
1983), glutamine synthetase (Young & Ringold,
1983), ornithine decarboxylase (McConlogue et al.,
1984), and UMP synthetase (Kanalas & Suttle,
1984). In addition a number of investigators have
reported a transport cross-resistance to a number of
alkaloids with overproduction of one or more
proteins and karyological and molecular evidence
of gene amplification (Roninson et al., 1984). There
are some 10-15 other examples of gene
amplification in somatic cells not listed here. Suffice
it to indicate that such amplification events occur
readily in somatic cells (see Schimke, 1984; Stark &
Wahl, 1984).
On the mechanism ofgene amplification
Studies in our laboratory have concentrated on the
mechanism whereby hydroxyurea (HU) enhances
the frequency of MTX resistance by virtue of gene
amplification (Brown et al., 1983). Mariani &
Schimke (1984) have concluded that transient (6h)
inhibition of DNA synthesis, upon resumption in
DNA synthesis, results in rereplication
(overreplication) of the DNA replicated prior to
inhibition of DNA synthesis in a subset of the cell
population. This effect is observed only in cells that
have progressed into the S-phase of the cell cycle.
We have shown that the overreplication process
involves not only the DHFR gene (which is
replicated within the first hour of S), but virtually
all of the DNA replicated prior to the onset of drug
inhibition of DNA synthesis. More recently we
have found (Johnston & Schimke, in preparation)
that the critical variable in generating cells with
additional DNA during recovery from inhibition of
DNA synthesis with HU is the duration of
inhibition of DNA replication. In the experiments
of Mariani & Schimke (1984) the length of the mid
s-phase block was 6h. We now find that 6h is aMETHOTREXATE RESISTANCE AND GENE AMPLIFICATION 461
minimal time for demonstration of overreplication
of DNA as indicated by the presence of cells with
more than a G2 complement of DNA/cell as
studied by flow cytometry and staining with either
Hoechsts 33342 or chromomycin A3. The
proportion of cells with greater than 2C DNA/cell
increases with time of inhibition of DNA synthesis,
when such cells are analyzed 24h after removal of
hydroxyurea. Hydroxyurea inhibits DNA synthesis
but virtue of inhibition of ribonucleotide reductase.
Similar results are obtained with the use of
aphidicolin, an antibiotic specific for inhibition of
DNA polymerase alpha of higher eukaryotes
(Johnston & Schimke, in preparation).
We conclude that the initial event in selective
gene amplification, e.g. of DHFR genes, is a non-
specific overreplication of DNA. Inasmuch as
DHFR is replicated in the first h of S-phase, it will
have a high probability of being involved in the
overreplication process. Various forms of recom-
bination occur subsequently to generate chromo-
somal or extrachromosomal genes, and the rare cell
with a productive recombination to generate a cell
with increased DHFR enzyme activity will
subsequently be selected. We wish to emphasize
that the majority of the overreplicated DNA is
unstable and will rapidly be lost in progeny that are
not under selective pressure.
Overreplication ofDNA and the generation of
various ofchromosomal abnormalities
We are currently exploring the hypothesis that
overreplication of DNA in a single cell cycle
generates free-ended, double-stranded DNA that is
highly recombinogenic (Schimke, 1984b). As long as
such overreplicated DNA does not "invade" the
sister chromatids in recombination, the structure of
the newly replicated sister chromatids is intact.
However, if such recombination occurs, it can
result in inversions, sister chromatid exchanges or
the generation of dicentric chromosomes, i.e.
breakage-bridge fusion chromosomes. Inversions
within HSR regions (Beidler et al., 1980) as well as
the presence of dicentric chromosomes (Fougere-
Deschatrette, (1984) with amplified DHFR genes
are common observations in karyotypes of cells
with highly amplified DHFR genes. If only one of
the two free DNA strands undergoes recombination
into the chromosome, the result is a cell with a
broken chromatid. Such cells cannot undergo a
round of DNA synthesis subsequent to the cell
cycle in which overreplication of DNA has
occurred, and, hence, are essentially "dead".
Hill and Schimke (in preparation) have subjected
mouse lymphoma cells (L5178Y) to a 6h treatment
with hydroxyurea and have analyzed such cells for
DNA content and a spectrum of chromosomal
aberrations as an immediate consequence of such
treatment. As shown in Figure 1, cells subjected to
transient inhibition of DNA synthesis result in a
subset of cells 24h later with increased DNA
content/cell. When cells treated in this manner are
analyzed by the fluorescence activated cell sorter,
and sorted for such cells with greater than 2C DNA
content, we observe that the major chromosomal
abberations occur in the cells with the greater than
2C DNA content. A shown in Table I, cells with
2C DNA content have normal chromosomes. In
contrast, 42% of chromosome spreads from cells
with greater than 2C content are abnormal. The
major aberrations include cells with fragmented
chromosomes, some element of endoreduplication,
or intact chromosomes with extrachromosomal
DNA. Figure 2 shows four representative karyo-
types showing (a) polyploidy, (b) intact chromo-
Table I Chromosomal changes in sorted cell populations after hydroxyurea
treatment.
% normal % polyploid % extra DNA %fragmented
No treatment
dull 100 0 0 0
bright 100 0 0 0
Hydroxyurea treatment
dull 92 0 0 0
bright 42 18 10 30
Mouse L5178Y cells in continuous growth were treated for 6h with 1.0mM
hydroxyurea, following which media was replaced with regular media. Colcemid was
added 12h later and cells were sorted for DNA content after staining with Hoechst's
33342 stain. "Dull" cells are those at the lower end of the fluorescence intensity.
"Bright" cells are those at the high end of fluorescence intensity ('l10 fluorescence
units, See Figure 1). Two hundred metaphase spreads were examined for karyological
abnormalities.462 R.T. SCHIMKE et al.
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Figure 1 Contour plots of L5178Y cell populations for DNA content analyzed by the fluorescence-activated
cell sorter. Cells were stained for 1 h with Hoechst 33342 to determine DNA content per cells (a) control cells:
15.8% of cells had a fluorescence intensity of 110 units or greater; (b) cells pretreated with 10mM
hydroxyurea for 6h and analyzed 24h after removal of hydroxyurea: 35.2% of the cells had a fluorescence
intensity of 110 units or greater. Contour plots are based on 10,000 cells; each line represents 20% of the
population.
somes with extrachromosomal chromosomal DNA,
(c) chromosomal fragmentation, (d) endore-
duplication. What is particularly important is that
the cells with the chromosomal aberrations occur
only among that subset of the cell population with
a DNA content/cell that is greater than 2C. Similar
results (i.e. increased DNA content/cell and
chromosomal aberrations) are also generated when
cells are treated with aphidicolin or cells treated in
mid S-phase with UV light and carcinogens (Tlsty
& Sherwood, in preparation). The type of data lead
us to suggest that the major rearrangements-
alterations in genomes occur as a consequence of
overreplication of DNA in a single cell cycle.
Discussion
This review has provided evidence for heterogeneity
of cultured cell populations when analyzed for the
parameter of ability to grow under the selective
conditions of MTX, a condition that frequently
results from selection of cells with amplified DHFR
genes. Further, our studies on the mechanism
indicate that gene amplification results from a two-
component process of initial overreplication of
extensive amounts of the cell genome, followed by
recombination events that allow expression and
replication of the amplified genes, whether they be
chromosomal or extrachromosomal.
Our results further suggest that a number of
treatments of cultured cells that result in a transient
inhibition of DNA synthesis in cells in S-phase
results in overreplication of DNA. The selectable
consequence of this process is drug resistance by
virtue of gene amplification. However, we also find
that the overreplication phenomenon results is a
vast number of chromosomal aberrations-
rearrangements. A majority of such chromosomal
alterations have little long-term consequence, in
that chromosomal fragmentation frequently results
in cell death. Similarly, if the overreplicated DNA
is extrachromosomal, it will be lost under non-
selective conditions. Certain cells, however, will
retain chromosomal rearrangements and/or
differing degrees of polyploidy, i.e. aneuploidy, and
there is likely to be random heterogeneity in those
DNA sequences that undergo initial
polyploidization-recombination events.
One can conceive of the process of tumour
generation as (at least) a two step process. The first
is the generation of cells that overcome normal
growth regulation, i.e. they can now divide
inappropriately. Such cells constitute a cancer.
However it is well known that some cancers are
"benign" and do not result in death, irrespective of
their size or time of existence. In terms of solid
tumours, according to Aver & Zetterberg (1984)
those tumours that result in death are those that
are aneuploid. Thus we suggest that a secondary
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Figure 2 Chromosomal aberrations induced by hydroxyurea. Metaphases were examined 24h after removal
of hydroxyurea and differentially stained sister chromatids were observed by FPG staining. (a) metaphase
with normal chromosomes and a large amount of small, extrachromosomal DNA (arrow); (b) metaphase with
multiple chromosome gaps and breaks; (c) and endoreduplicated metaphase with a large number of sister
chromatid exchanges; (d} metaphase with fragmented chromosomes (arrow) showing a large number of sister
chromatid exchanges.
process leading to lethal tumorigenesis is the
generation of aneuploidy and the subsequent
selection of certain cells from such populations with
increased growth-metastatic potential. We suggest
that this process results from loss of replication
control (as opposed to growth control) such that
overreplication of DNA occurs with the
consequence of generation of aneuploidy. Among
such consequences are, indeed, amplification of
specific oncogenes, as observed both in continuous
cell lines derived from tumours, as well as in
tumour cell populations per se (see Schimke, 1984).
Our laboratory studies raise several questions
concerning cancer and cancer treatment. Could not
the heterogeneity observed in tumours result from
the generation of aneuploidy, such heterogeneity
itself resulting from imbalances in gene dosages,
gene amplification, or recombinational inactivation-464 R.T. SCHIMKE et al.
activation of specific genes? If there is indication
that the answer to this question might be yes, then
a major question follows: do not many of the
cancer treatment modalities result in overreplication
of DNA, the consequence of which is generation of
chromosomal aberrations? Might such treatments
convert relatively benign tumours into a state of
aneuploidy and progression to more lethal form?
Indeed, treatment of an experimental tumour with
cancer chemotherapeutic agents has been shown to
increase heterogeneity in DNA/cell (deVere White,
1983).
R.T.S. is American Cancer Society Research Professor of
Biology. Supported by research grants from the National
Institute of General Medical Sciences (GM 14931) and the
National Cancer Institute (CA 13831).
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